CNBC's Jim Cramer walked investors through another week of earnings season, highlighting reports from Berkshire Hathaway, McDonald's and Eli Lilly. He also honed in on earnings from Marriott, ...

President Donald Trump's new European tariffs could significantly increase the cost of Novo Nordisk's weight loss drug, Ozempic.

Pharmaceutical stocks slumped after President Donald Trump sent letters to 17 drugmakers with an ultimatum to reduce drug ...

Both Novo Nordisk's Wegovy and rival Eli Lilly's Zepbound are essentially versions of predecessor diabetes drugs. Some ...